+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Darifenacin"

From
From
From
From
From
Global and Chinese Darifenacin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Darifenacin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 139 Pages
  • Global, China
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Darifenacin is a drug used to treat overactive bladder, a condition characterized by urinary urgency, frequency, and incontinence. It is a muscarinic receptor antagonist, meaning it works by blocking the action of acetylcholine, a neurotransmitter that causes bladder contractions. Darifenacin is available in both immediate-release and extended-release formulations. It is typically taken once daily, with or without food. Common side effects include dry mouth, constipation, and blurred vision. Darifenacin is used to treat a variety of urological disorders, including overactive bladder, urinary incontinence, and urinary retention. It is also used to reduce the risk of urinary tract infections. Darifenacin is available in generic and brand-name formulations. Several companies manufacture and market Darifenacin, including Astellas Pharma, Inc., Mylan Pharmaceuticals, Inc., and Teva Pharmaceuticals USA, Inc. Show Less Read more